SUMO1 overexpression in Non-small cell lung cancer (NSCLC) is linked to a more aggressive tumor phenotype and poorer prognosis, likely through its promotion of NF-κB activity and subsequent regulation of genes involved in tumor cell proliferation, invasion, and metastasis(Ke et al. 2019). Here, SUMO1 is linked to non-small cell lung carcinoma.